Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 10.60% over the last 5 years
Flat results in Sep 25
With ROE of 18.7, it has a Very Expensive valuation with a 6.4 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Underperformed the market in the last 1 year
Stock DNA
Electrodes & Refractories
INR 859 Cr (Micro Cap)
34.00
12
1.22%
-0.11
18.66%
6.43
Total Returns (Price + Dividend) 
Latest dividend: 19 per share ex-dividend date: Aug-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Morganite Crucible (India) Sees Shift in Technical Momentum Amid Mixed Indicators
Morganite Crucible (India), a key player in the Electrodes & Refractories sector, has experienced a notable shift in its technical momentum as recent evaluation adjustments reveal a transition from a mildly bearish trend to a sideways movement. This development comes amid a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term trajectory.
Read More
Morganite Crucible (India) Ltd is Rated Sell
Morganite Crucible (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Morganite Crucible (India) Sees Shift in Technical Momentum Amid Mixed Market Signals
Morganite Crucible (India), a key player in the Electrodes & Refractories sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a mildly bullish to a mildly bearish trend, underscoring evolving investor sentiment and technical dynamics.
Read More Announcements 
Letter of Offer
18-Dec-2025 | Source : BSEJM Financial Ltd (Manager to the Offer) has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Morganite Crucible India Ltd (Target Company).
Disclosure Under PIT Reg
18-Nov-2025 | Source : BSEWe would like to inform you that the Company has received disclosure for dispose of securities by promoters under Reg 7(2)(a) Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 aggregates to a traded value in excess of ten lakh rupees.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
14-Nov-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Morgan Terrassen B.V.
Corporate Actions 
No Upcoming Board Meetings
Morganite Crucible (India) Ltd has declared 380% dividend, ex-date: 14 Aug 25
Morganite Crucible (India) Ltd has announced 5:10 stock split, ex-date: 31 Aug 20
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (0.18%)
Morganite Crucible Limited (38.5%)
Pgim India Equity Growth Opportunities Fund-series I (1.11%)
20.02%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 7.97% vs 0.52% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 52.17% vs 100.35% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 1.46% vs -0.95% in Sep 2024
Growth in half year ended Sep 2025 is -13.44% vs 4.28% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 2.98% vs 6.16% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 8.21% vs 61.17% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 3.73% vs 8.63% in Mar 2024
YoY Growth in year ended Mar 2025 is 17.24% vs 45.72% in Mar 2024






